Patents by Inventor Astrid FRIEDLI

Astrid FRIEDLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9850256
    Abstract: The invention relates to antibacterial compounds of formula I wherein R1a, R2a, R2b, R3a, R3b, R4, R5, U1, U2, U3, U4, V1, V2, V3, V4, X and Q and n are as defined in the specification. It further relates pharmaceutical compositions containing these compounds and the uses of these compounds in the manufacture of medicaments for the treatment of bacterial infections. These compounds are useful antimicrobial agents effective against a variety of human and veterinary pathogens including among others Gram-positive and Gram-negative aerobic and anaerobic bacteria.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: December 26, 2017
    Assignee: IDORSIA PHARMACEUTICALS LTD
    Inventors: Sylvaine Cren, Astrid Friedli, Georg Rueedi, Cornelia Zumbrunn
  • Publication number: 20170305927
    Abstract: The invention relates to antibacterial compounds of formula I wherein R1a, R2a, R2b, R3a, R3b, R4, R5, Ul, U2, U3, U4, V1, V2, V3, V4, X and Q and n are as defined in the specification. It further relates pharmaceutical compositions containing these compounds and the uses of these compounds in the manufacture of medicaments for the treatment of bacterial infections. These compounds are useful antimicrobial agents effective against a variety of human and veterinary pathogens including among others Gram-positive and Gram-negative aerobic and anaerobic bacteria.
    Type: Application
    Filed: October 14, 2015
    Publication date: October 26, 2017
    Inventors: Sylvaine CREN, Astrid FRIEDLI, Georg RUEEDI, Cornelia ZUMBRUNN
  • Patent number: 9527867
    Abstract: The invention relates to antibacterial compounds of formula I and salts thereof and methods of treating bacterial infection using the compounds.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: December 27, 2016
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Sylvaine Cren, Astrid Friedli, Christian Hubschwerlen, Georg Rueedi, Cornelia Zumbrunn
  • Publication number: 20160075722
    Abstract: The invention relates to antibacterial compounds of formula I (I) wherein R is H, cyano, alkoxy, cyanomethoxy, cycloalkylmethoxy, hydroxyalkoxy, alkoxyalkoxy, alkoxycarbonyl, 2-ethoxy-2-oxoethoxy, 2-(methylamino)-2-oxoethoxy, (1-cyanocyclobutyl)methoxy, 3-hydroxy-pyrrolidin-1-yl or 3,4-dihydroxycyclopentyl)methoxy; U1 is N or CR1, U2 is N or CR1, U3 is N or CR3 and U4 is N or CR1, it being understood that at most three of U1, U2, U3 and U4 can be N at the same time; V1 is N or CR5, V2 is N or CR6, V3 is N or CR7 and V4 is N or CH, it being understood that at most two of V1, V2, V3 and V4 can be N at the same time; R1 is H, cyano, hydroxy or alkoxy; R2 is H, hydroxy or alkoxy; R3 is H, cyano, hydroxy, alkoxy or carboxamido; R4 is H or alkoxy; R5 is H, hydroxy or halogen; R6 is H, hydroxy or halogen; R7 is H; the dotted line “______” represents a bond or is absent; W represents CH or N when the dotted line “______” is a bond, or W represents CH2 when the dotted line “______” is absent; X represents CH or N; and
    Type: Application
    Filed: April 15, 2014
    Publication date: March 17, 2016
    Inventors: Sylvaine CREN, Astrid FRIEDLI, Christian HUBSCHWERLEN, Georg RUEEDI, Cornelia ZUMBRUNN